Navigation Links
MedBox Announces Ticker Symbol Change
Date:11/8/2011

HOLLYWOOD, Calif., Nov. 8, 2011 /PRNewswire/ -- MedBox (Pink Sheets: MDBX) (www.thedispensingsolution.com), announced today that they have changed their ticker symbol to MDBX.  The company previously announced that their name was changing from MindfulEye to MedBox.

The company is a leader in the design, manufacture and distribution of automated dispensing systems of prescription medicines. The free-standing unit features 60 or more slots that can accommodate a wide variety of medicines and dosages, and is protected by both a military grade reinforced steel framework and an advanced bio-metrics fingerprint recognition system.

MedBox is a patented dispensing system and software program that utilizes special identification cards that are encoded with the patient's unique fingerprint and prescription allotment information. The process allows for pharmacies, hospitals, and clinics to document that the patient visiting the machine is a registered patient and that the patient has a valid and unexpired authorization from a physician to possess and use the medicine. Each transaction is tracked internally for accounting and compliance purposes. Patient information is all kept securely onsite and not online, as the software is completely self-supportive and does not require an internet connection.

The system has many benefits, which include:

  • Inventory control for operators
  • Safe and convenient access for patients,
  • Decreased overhead
  • Limitations on amounts dispensed to patients
  • Fraud prevention as every transaction is documented
  • Accurate taxation reporting to cities and states

By placing this system in a conventional pharmacy, owners and operators can reduce the long lines and uncomfortable waits that customers endure, and minimize the necessity for employee interaction on simple refills on standard items. This reduces overhead, streamlines operations and provides added convenience for the customer.

The units are built by AVT, Inc – one of the nation's leading developers of automated retailing systems.

"We offer systems that benefit both the patrons that receive their medication though our machines as well as the pharmacies that utilize our technology", states Vincent Mehdizadeh, CEO of MedBox. "The patrons get quick and convenient access to their medication, while the pharmacies gain increased inventory awareness, unparalleled accuracy, and lower overhead costs". 

MedBox is now traded on the OTC Board, ticker symbol MDBX.

About MedBox:  

MedBox is a leader in the automated dispensing of medicines, and has offices throughout the world, including New York, Tokyo and the corporate headquarters in Los Angeles. The system has been praised by virtually all parties because it reduces fraud, waste and abuse. The system provides accurate taxation reports, as the transaction logs cannot be modified. Limits can be set as to how much medicine the machine can dispense to patients (per day, week, month, etc.), as well as documents possible misuse if patients are registered at multiple locations and are accumulating large quantities of medicine. The machines will not dispense to patients that are not registered and do not possess an identification card, fail fingerprint verification, have an expired prescription or have reached their dispensing limit (if applicable). The system software will not permit registration to individuals under the age of 21 and will not dispense to those individuals.

MedBox provides their proprietary, patented system and consulting services to pharmacies, clinics, hospitals, and medical groups worldwide.


'/>"/>
SOURCE MedBox
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SMT Research & Development, Ltd. Names Shuki Porath as Vice President and General Manager, Announces TCT Presence
2. ECRI Institute Announces its Top 10 Health Technology Hazards for 2012
3. Echo Therapeutics Announces Third Quarter 2011 Financial Results
4. International Isotopes Inc. Announces the Completion of an Agreement in Principle With Idaho State University for the Production of Copper-67 for Experimental Use in Cancer Treatment
5. Cardiac Dimensions Announces Presentation of Two-Year Efficacy Data From TITAN Clinical Trial
6. NephroGenex Announces the Successful Completion of PYR-210
7. Mindray Announces Up to $100 Million Share Repurchase Program
8. Mindray Announces Third Quarter 2011 Financial Results
9. Delcath Announces Fiscal 2011 Third Quarter Results and Recent Developments
10. Hologic Announces Fourth Quarter and Fiscal 2011 Operating Results
11. Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib at 53rd American Society of Hematology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... , July 21, 2017  Endo International plc ... completing a comprehensive review of its manufacturing network, the ... and distribution facilities in Huntsville, Alabama ... take place over the next 12 to 18 months. ... impacted by declining volumes of commoditized products and these ...
(Date:7/20/2017)... PAUL, Minn. , July 20, 2017  Prime Therapeutics ... Jonathan Gavras , M.D., following today,s Institute for Clinical ... report on the effectiveness and value of abuse-deterrent ... manager on the policy roundtable at the meeting. ... is not a material cost benefit to the use of ...
(Date:7/17/2017)... 17, 2017  MedX Holdings, Inc., the manufacturer and ... and rehabilitation equipment, today announced the national roll out ... considered the gold standard for the treatment of low ... strengthening equipment. How ... physician or practice who prescribe the MedX Home Back ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... financial consultation services to families and business owners in the Dalton region, is ... support for children overcoming sexual assault and physical abuse. , The GreenHouse is ...
(Date:7/21/2017)... ... July 21, 2017 , ... Adolfson ... renovate and improve the Ramsey County Medical Examiners Facility located in Saint Paul, ... $2.5 million project is scheduled to start in late 2017/early 2018. , ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm ... the contents of its ginger ale for allegedly containing no ginger. Dr. Pepper produces ... Snapple Group, Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/20/2017)... ... July 20, 2017 , ... TransPixel Volume 2 is ... clips in the FCPX timeline. This effect isolates horizontal and vertical lines of pixels ... contains either a rotating or flipping animation and can be changed using a drop-down ...
Breaking Medicine News(10 mins):